Deepnoid

딥노이드 · 315640

Information Technology Software · KOSDAQ

Small-cap

Market cap US$51.1M (₩70.5B)

Overview

Deepnoid develops artificial-intelligence software that helps doctors detect potential brain aneurysms, lung disease, and lung nodules in medical scans, and separately supplies AI systems that automatically flag dangerous or prohibited items in X-ray security screening and spot defects on factory production lines.

Its medical-AI products are supplied to hospitals and health-screening centres, while its industrial-AI products serve airports, government agencies, data centres, and manufacturers. Listed on KOSDAQ, Korea's tech-focused stock exchange, the company operates across two distinct divisions, medical AI and industrial AI, each generating revenue through a mix of one-time sales and recurring usage-based fees.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$5.4M
▼ −31.1% YoY
Operating profit · FY2025
−US$7.7M
Loss widened
Net income · FY2025
−US$7.8M
Loss widened

Revenue

  • FY2023US$1.4M
  • FY2024US$7.9M
  • FY2025US$5.4M

Operating profit

  • FY2023−US$4.9M
  • FY2024−US$7.3M
  • FY2025−US$7.7M

Net income

  • FY2023−US$4.9M
  • FY2024−US$6.6M
  • FY2025−US$7.8M

Key ratios (FY2025)

ROE
-37.7%
Debt/Eq
42.0%
Op. margin
-141.3%
Net margin
-143.8%
Rev. YoY
▼ −31.1%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.